SCID/human mouse model of central nervous system lymphoproliferative disease

R. Bashir, M. Okano, K. Kleveland, Samuel Jay Pirruccello, A. Masih, W. Sanger, R. Fordyce-Boyer, D. Purtilo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Epstein-Barr virus (EBV) carrying malignant lymphomas of the central nervous system are increasing owing to the increasing numbers of immunodeficient patients. To further understand the pathogenesis of these tumors, we studied the invasiveness of four EBV-immortalized lymphoblastoid cell lines in the brains of immunodeficient mice and the expression of adhesion molecules during this process. We injected four EBV-infected human lymphoblastoid cell lines intracerebrally into nude as well as SCID/SCID CB17 mice. Within 13 to 14 days, lethal brain lymphoproliferative lesions resulted in SCID mice, whereas similar lesions developed in 21 to 24 days in nude mice. Atypical large lymphoid cells aggressively infiltrated brain parenchyma, ventricular, and subarachnoid spaces. No difference in invasiveness was found between the monoclonal lymphoblastoid cell lines grown in long-term culture and polyclonal lymphoblastoid cell lines grown for a shorter duration. Tumors retained the same human immunoglobulin expression and activation antigen profile as the original cell lines. Furthermore, tumors expressed human LFA-1/ICAM-1 and the tumor blood vessels strongly expressed murine ICAM-1, but not MECA 79. Mice injected intracerebrally with peripheral blood leukocytes or normal bone marrow cells from an EBV seronegative individual failed to form tumors confirming the pivotal role for EBV in this process. SCID mice offer advantages for studying central nervous system lymphoproliferative disease.

Original languageEnglish (US)
Pages (from-to)702-709
Number of pages8
JournalLaboratory Investigation
Volume65
Issue number6
StatePublished - Dec 1 1991

Fingerprint

SCID Mice
Central Nervous System Diseases
Human Herpesvirus 4
Cell Line
Intercellular Adhesion Molecule-1
Neoplasms
Brain
Vascular Tissue Neoplasms
Lymphocyte Function-Associated Antigen-1
Subarachnoid Space
Nude Mice
Bone Marrow Cells
Immunoglobulins
Lymphoma
Leukocytes
Central Nervous System
Lymphocytes
Antigens

Keywords

  • Brain tumor
  • Epstein-Barr virus
  • LCL brain tumor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Bashir, R., Okano, M., Kleveland, K., Pirruccello, S. J., Masih, A., Sanger, W., ... Purtilo, D. (1991). SCID/human mouse model of central nervous system lymphoproliferative disease. Laboratory Investigation, 65(6), 702-709.

SCID/human mouse model of central nervous system lymphoproliferative disease. / Bashir, R.; Okano, M.; Kleveland, K.; Pirruccello, Samuel Jay; Masih, A.; Sanger, W.; Fordyce-Boyer, R.; Purtilo, D.

In: Laboratory Investigation, Vol. 65, No. 6, 01.12.1991, p. 702-709.

Research output: Contribution to journalArticle

Bashir, R, Okano, M, Kleveland, K, Pirruccello, SJ, Masih, A, Sanger, W, Fordyce-Boyer, R & Purtilo, D 1991, 'SCID/human mouse model of central nervous system lymphoproliferative disease', Laboratory Investigation, vol. 65, no. 6, pp. 702-709.
Bashir R, Okano M, Kleveland K, Pirruccello SJ, Masih A, Sanger W et al. SCID/human mouse model of central nervous system lymphoproliferative disease. Laboratory Investigation. 1991 Dec 1;65(6):702-709.
Bashir, R. ; Okano, M. ; Kleveland, K. ; Pirruccello, Samuel Jay ; Masih, A. ; Sanger, W. ; Fordyce-Boyer, R. ; Purtilo, D. / SCID/human mouse model of central nervous system lymphoproliferative disease. In: Laboratory Investigation. 1991 ; Vol. 65, No. 6. pp. 702-709.
@article{76977c7216be4b848ef9d81f8f1cb163,
title = "SCID/human mouse model of central nervous system lymphoproliferative disease",
abstract = "Epstein-Barr virus (EBV) carrying malignant lymphomas of the central nervous system are increasing owing to the increasing numbers of immunodeficient patients. To further understand the pathogenesis of these tumors, we studied the invasiveness of four EBV-immortalized lymphoblastoid cell lines in the brains of immunodeficient mice and the expression of adhesion molecules during this process. We injected four EBV-infected human lymphoblastoid cell lines intracerebrally into nude as well as SCID/SCID CB17 mice. Within 13 to 14 days, lethal brain lymphoproliferative lesions resulted in SCID mice, whereas similar lesions developed in 21 to 24 days in nude mice. Atypical large lymphoid cells aggressively infiltrated brain parenchyma, ventricular, and subarachnoid spaces. No difference in invasiveness was found between the monoclonal lymphoblastoid cell lines grown in long-term culture and polyclonal lymphoblastoid cell lines grown for a shorter duration. Tumors retained the same human immunoglobulin expression and activation antigen profile as the original cell lines. Furthermore, tumors expressed human LFA-1/ICAM-1 and the tumor blood vessels strongly expressed murine ICAM-1, but not MECA 79. Mice injected intracerebrally with peripheral blood leukocytes or normal bone marrow cells from an EBV seronegative individual failed to form tumors confirming the pivotal role for EBV in this process. SCID mice offer advantages for studying central nervous system lymphoproliferative disease.",
keywords = "Brain tumor, Epstein-Barr virus, LCL brain tumor",
author = "R. Bashir and M. Okano and K. Kleveland and Pirruccello, {Samuel Jay} and A. Masih and W. Sanger and R. Fordyce-Boyer and D. Purtilo",
year = "1991",
month = "12",
day = "1",
language = "English (US)",
volume = "65",
pages = "702--709",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - SCID/human mouse model of central nervous system lymphoproliferative disease

AU - Bashir, R.

AU - Okano, M.

AU - Kleveland, K.

AU - Pirruccello, Samuel Jay

AU - Masih, A.

AU - Sanger, W.

AU - Fordyce-Boyer, R.

AU - Purtilo, D.

PY - 1991/12/1

Y1 - 1991/12/1

N2 - Epstein-Barr virus (EBV) carrying malignant lymphomas of the central nervous system are increasing owing to the increasing numbers of immunodeficient patients. To further understand the pathogenesis of these tumors, we studied the invasiveness of four EBV-immortalized lymphoblastoid cell lines in the brains of immunodeficient mice and the expression of adhesion molecules during this process. We injected four EBV-infected human lymphoblastoid cell lines intracerebrally into nude as well as SCID/SCID CB17 mice. Within 13 to 14 days, lethal brain lymphoproliferative lesions resulted in SCID mice, whereas similar lesions developed in 21 to 24 days in nude mice. Atypical large lymphoid cells aggressively infiltrated brain parenchyma, ventricular, and subarachnoid spaces. No difference in invasiveness was found between the monoclonal lymphoblastoid cell lines grown in long-term culture and polyclonal lymphoblastoid cell lines grown for a shorter duration. Tumors retained the same human immunoglobulin expression and activation antigen profile as the original cell lines. Furthermore, tumors expressed human LFA-1/ICAM-1 and the tumor blood vessels strongly expressed murine ICAM-1, but not MECA 79. Mice injected intracerebrally with peripheral blood leukocytes or normal bone marrow cells from an EBV seronegative individual failed to form tumors confirming the pivotal role for EBV in this process. SCID mice offer advantages for studying central nervous system lymphoproliferative disease.

AB - Epstein-Barr virus (EBV) carrying malignant lymphomas of the central nervous system are increasing owing to the increasing numbers of immunodeficient patients. To further understand the pathogenesis of these tumors, we studied the invasiveness of four EBV-immortalized lymphoblastoid cell lines in the brains of immunodeficient mice and the expression of adhesion molecules during this process. We injected four EBV-infected human lymphoblastoid cell lines intracerebrally into nude as well as SCID/SCID CB17 mice. Within 13 to 14 days, lethal brain lymphoproliferative lesions resulted in SCID mice, whereas similar lesions developed in 21 to 24 days in nude mice. Atypical large lymphoid cells aggressively infiltrated brain parenchyma, ventricular, and subarachnoid spaces. No difference in invasiveness was found between the monoclonal lymphoblastoid cell lines grown in long-term culture and polyclonal lymphoblastoid cell lines grown for a shorter duration. Tumors retained the same human immunoglobulin expression and activation antigen profile as the original cell lines. Furthermore, tumors expressed human LFA-1/ICAM-1 and the tumor blood vessels strongly expressed murine ICAM-1, but not MECA 79. Mice injected intracerebrally with peripheral blood leukocytes or normal bone marrow cells from an EBV seronegative individual failed to form tumors confirming the pivotal role for EBV in this process. SCID mice offer advantages for studying central nervous system lymphoproliferative disease.

KW - Brain tumor

KW - Epstein-Barr virus

KW - LCL brain tumor

UR - http://www.scopus.com/inward/record.url?scp=0026356709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026356709&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 702

EP - 709

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 6

ER -